NSE: YATHARTH · BSE: 543950 · ISIN INE0JO301016
Yatharth Hospital & Trauma Care Services Limited stock analysis
Yatharth Hospital & Trauma Care Services Limited ranks #1019 in the TickerSutra evidence-ranked universe with a score of 57/100 and 95% data confidence. The latest captured fundamentals show ROCE of 12.4%, quarterly sales growth of 52.3% and quarterly profit growth of 11.9%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- Low debt/equity of 0.15×
- 36.2% three-year sales CAGR
- CWIP indicates an active capacity pipeline
Risks and constraints
- Promoter pledge is 9.6% of promoter holding
- Valuation is above 40× earnings
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹375cr | ₹112cr | ₹44cr | 30.0% |
| 2023 | ₹478cr | ₹135cr | ₹66cr | 28.0% |
| 2024 | ₹635cr | ₹182cr | ₹114cr | 29.0% |
| 2025 | ₹860cr | ₹225cr | ₹131cr | 26.0% |
| 2026 | ₹1,207cr | ₹292cr | ₹170cr | 24.0% |
| TTM | ₹1,334cr | ₹310cr | ₹174cr | 23.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Yatharth Hospital & Trauma Care Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
RoutineYatharth Hospital & Trauma Care Services Ltd - 543950 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · 26 Sept 2026We hereby submit the Scrutinizer''s Report of 19th Annual General Meeting of the Company held on September 25, 2026.
RoutineShareholders meetingNSE · 26 Sept 2026We hereby submit Voting Results and Scrutinizer Report of the 19th Annual General Meeting held on September 25, 2026.
RoutineYatharth Hospital & Trauma Care Services Ltd - 543950 - Voting Results Of The 19Th Annual General Meeting.BSE · 26 Sept 2026We hereby submit the Voting Results of the 19th Annual General Meeting of the Company held on September 25, 2026.
RoutineShareholders meetingNSE · 25 Sept 2026We hereby submit the summary of the Proceedings of 19th Annual General Meeting of the Company held today i.e. September 25, 2026.
MANAGEMENT COMMENTARY
Signals from filed documents
By scaling our operations within existing geographies and selectively expanding into adjacent regions, we enhance brand visibility, improve operational efficiencies, and broaden access to advanced healthcare services. Our Strategic Pillars Deepening Leadership in Existing Clusters Selective Geographic Expansion Replicating a Proven Operating Model Driving Synergies Across the Network Expand capacity and strengthen ma
Strengthened brand visibility through awareness initiatives in partnership with the African Students Union. Advanced empanelment efforts and referral partnerships across priority international markets. presence across Noida and the NCR, we are building a seamless ecosystem for international patients seeking advanced and specialised healthcare services in India.
With the upcoming Gurugram facility and brownfield expansion plan at Noida Extension and Greater Noida, our total bed capacity will reach over 3,200 beds. We remain confident of achieving our target of 5,000 beds over the next few years. FY27 has started on a strong note and the early success of our newer facilities gives us a confidence in sustaining this momentum.
The increase in depreciation and finance costs have been following the significant capacity addition made over the past 12 Yatharth Hospitals and Trauma Care Services Limited August 11, 2026 Page 5 of 19 Corporate Office: Second Floor, Sovereign Capital Gate, FC-12 Sector 16A, Noida – 201301 CIN: L85110DL2008PLC174706 months, despite which our cash profit, which is PAT plus depreciation increased significantly by 32%
Our performance across these hospitals demonstrates the Group's ability, not only to identify and acquire good assets, but also to integrate and turnaround their operations within a very short span of time. Over the past couple of quarters, our profitability has also improved meaningfully with operating leverage kicking in as reflected in our adjusted EBITDA margin, excluding the impact of New Delhi and Faridabad sec
Strong and effective governance presents an opportunity to enhance transparency, accountability and responsible decision- making across the organisation. A robust governance framework can strengthen regulatory compliance, risk management, patient safety and data protection while fostering an ethical and performance-driven organisational culture. By maintaining effective Board oversight, clear policies and internal co
We further report that: a) The Board of Directors of the Company was duly constituted with an appropriate balance of Executive Directors, Non-Executive Directors, and Independent Directors during the financial year. Ramesh Krishnan was appointed as an Independent Director of the Company with effect from November 5, 2025, and his appointment was subsequently approved by the shareholders on January 15, 2026. Nagpal Ass
Amit Kumar Singh: Yes, sir, recently got this news, so I think there's a recommendation about the stealing of the room rent. So, as of now, there's no comment, but see, price increase -- there are various regions and various factors on the price increase there. So how this entire ecosystem gets managed, that's very, very important.
Also, the Company has neither issued shares with differential voting rights nor granted any stock options. Updates on Utilization of funds raised through IPO and QIP The Company had raised funds through Qualified Institutional Placement (“QIP”) and Initial Public Offering (“IPO”). The proceeds raised through the QIP have been fully utilized and was duly reported and disclosed in the Monitoring Agency Report for the q
MANAGEMENT PROMISE LEDGER
Quantified statements on the clock
“So, we have always mentioned that I think upwards of 24% is what we're ta rgeting for the EBITDA margin this year, and I think going forward, yes, a percentage up or so in few years is expected, but we're not targeting a 28% EBITDA margin anytime soon, even at the consolidated group level. Vedant Kabra: So, sir, if you could like give a quantification on the possible operating leverage, for example, for a hospital li”
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…